Summit Global Investments’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.46M Sell
110,952
-34,374
-24% -$3.06M 0.56% 20
2025
Q4
$11.5M Sell
145,326
-61,893
-30% -$4.85M 0.68% 18
2025
Q3
$16.6M Buy
207,219
+31,509
+18% +$2.69M 0.97% 13
2025
Q2
$16M Buy
175,710
+960
+0.5% +$87.6K 0.94% 12
2025
Q1
$16.4M Sell
174,750
-115,279
-40% -$10.3M 1.19% 9
2024
Q4
$26.4M Buy
290,029
+123,322
+74% +$11.8M 1.65% 6
2024
Q3
$17.3M Buy
166,707
+3,105
+2% +$316K 1.1% 15
2024
Q2
$15.9M Sell
163,602
-11,619
-7% -$1.07M 1.07% 17
2024
Q1
$15.8M Buy
175,221
+95,440
+120% +$8.09M 1.17% 17
2023
Q4
$6.36M Sell
79,781
-207,604
-72% -$15.6M 0.42% 52
2023
Q3
$20.4M Buy
287,385
+204,875
+248% +$15.3M 1.36% 9
2023
Q2
$6.36M Buy
+82,510
New +$6.39M 0.42% 63
2022
Q2
Sell
-45,564
Closed -$3.46M 474
2022
Q1
$3.46M Buy
45,564
+43,183
+1,814% +$3.42M 0.25% 100
2021
Q4
$203K Buy
+2,381
New +$186K 0.01% 504
2021
Q1
Sell
-70,177
Closed -$6M 551
2020
Q4
$6M Sell
70,177
-28,832
-29% -$2.38M 0.6% 41
2020
Q3
$7.64M Sell
99,009
-27,490
-22% -$2.1M 0.79% 39
2020
Q2
$9.27M Sell
126,499
-32,232
-20% -$2.29M 1.07% 33
2020
Q1
$10.5M Sell
158,731
-44,453
-22% -$3.14M 1.54% 23
2019
Q4
$14M Buy
203,184
+3,888
+2% +$265K 1.52% 17
2019
Q3
$14.7M Buy
199,296
+78,274
+65% +$5.68M 1.7% 11
2019
Q2
$8.67M Buy
121,022
+109,901
+988% +$7.8M 1.09% 30
2019
Q1
$762K Sell
11,121
-2,860
-20% -$185K 0.1% 133
2018
Q4
$832K Sell
13,981
-62,664
-82% -$3.92M 0.13% 112
2018
Q3
$5.13M Buy
76,645
+1,546
+2% +$103K 0.69% 52
2018
Q2
$4.87M Buy
75,099
+14,433
+24% +$944K 0.73% 49
2018
Q1
$4.35M Buy
60,666
+13,191
+28% +$949K 0.69% 44
2017
Q4
$3.58M Sell
47,475
-734
-2% -$53.6K 0.55% 51
2017
Q3
$3.51M Buy
48,209
+25,893
+116% +$1.87M 0.55% 53
2017
Q2
$1.65M Sell
22,316
-21,502
-49% -$1.6M 0.5% 54
2017
Q1
$3.21M Buy
43,818
+9,201
+27% +$644K 1.04% 28
2016
Q4
$2.27M Buy
+34,617
New +$2.37M 0.82% 38

Other funds holding CL

Summit Global Investments's CL Position: Q1 2026 in Review

Summit Global Investments reduced its Colgate-Palmolive (CL) stake by 24% in Q1 2026, selling an estimated $3.06M and leaving 110,952 shares worth $9.46M. The position accounts for 0.56% of the portfolio, ranked #20.

Summit Global Investments first reported a position in CL in Q4 2016 and has held it in 31 quarters since. The position peaked at $26.4M in Q4 2024. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Summit Global Investments held 110,952 shares of Colgate-Palmolive worth $9.46M as of Q1 2026.
  • Summit Global Investments sold 34,374 Colgate-Palmolive shares in Q1 2026, an estimated $3.06M.
  • Colgate-Palmolive made up 0.56% of Summit Global Investments's portfolio in Q1 2026, its #20 holding.
  • Summit Global Investments first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 31 quarters since.
  • Summit Global Investments's Colgate-Palmolive position peaked at $26.4M in Q4 2024.
  • 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Summit Global Investments's 13F filing for Q1 2026, filed 7 May 2026.